Dr. Jeffrey Matous on Managing Access to Novel Agents in the Community Setting
Held on March 18, 2026, from 12:30–1:00 PM CST with Jeffrey Matous presenting "Managing Access to Novel Agents in the Community Setting."
Community Oncology
Community Oncology
Cellular Therapy
Tara Graff on Implementing bispecific antibodies in community practice
Live session held on February 11, 2026, from 2:00–2:30 PM CST with speaker Tara Graff presenting on "Implementing Bispecific Antibodies in Community Practice."
Community Oncology
Manali Kamdar on Expanding access to CAR T-cell therapy outside academic centers
Manali Kamdar, MD, will present at 4:30–5 pm on January 20, 2026, on “Expanding access to CAR T-cell therapy outside academic centers.”
Leukemia News
SOHO 2025
News
Video Interviews
Drs. Jabbour, Logan, and Aldoss discuss treatment advancements in ALL
In this panel discussion at the Thirteenth Annual Meeting of the Society of Hematologic Oncology (SOHO 2025), Elias Jabbour, MD, leukemia professor at
Multiple Myeloma
News
FDA adds enterocolitis risk warning to approved CAR-T cell therapy
The US Food and Drug Administration (FDA) approved updates to the prescribing information for ciltacabtagene autoleucel (CARVYKTI). The agency added a boxed warning
Cellular Therapy
Lymphoma
Mantle Cell Lymphoma
Liso-cel receives expanded approval in R/R MCL by European Commission
The European Commission expanded approval of the CD19-directed chimeric antigen receptor T-cell therapy lisocabtagene maraleucel (liso-cel; Breyanzi®) in patients with relapsed or refractory
Multiple Myeloma
Video Interviews
Dr. Abdallah on blenrep combo approval in relapsed myeloma
In this video interview with SOHO Insider Al-Ola A. Abdallah, MD, associate professor and director of the Plasma Cell Disorder program at the
Lymphoma
Indolent B-Cell Lymphomas
News
FDA approves epcoritamab combo in R/R follicular lymphoma
The US Food and Drug Administration (FDA) approved epcoritamab (EPKINLY) in combination with rituximab, lenalidomide, and lenalidomide (RLL) for adult patients with relapsed
Ambassador Program
News
Society Updates
SOHO Egypt 2025 debuts with 2-day meeting in Cairo
The inaugural SOHO-EGYPT Meeting (November 5 to 6) was a joint session within NCI's BGO 2025 Congress ("Bridging Gaps in Oncology," November 5
Multiple Myeloma
News
Society Updates
Young Investigator Program
SOHO Young Investigator spotlight: Meet Maha Hameed, MD
As a resident physician who is fascinated by hematologic malignancies, Maha Hameed, MD, brings a distinctive combination of scientific intrigue and personal drive